Abstract

REVIEW ON ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF EMPAGLIFLOZIN

Zeel M. Modi*, Jinal Goswami, Dr. Khushbu Patel, Khushbu S. Patel, Dr. C. N. Patel

.

Abstract

Antidiabetic medicines treat diabetes mellitus by reducing blood glucose levels. Antidiabetic medicines are primarily classified as oral hypoglycemic agents and insulin preparations. Empagliflozin is an oral hypoglycemic agent. Empagliflozin is an SGLT 2 inhibitor, a kind of diabetes drug that targets transporters in the kidney's proximal tubules to reduce blood glucose levels by increasing glucosuria. It includes information on the development of several analytical methods such as UV, HPLC, HPTLC, and QbD-based HPLC methods, allowing us to employ any method for further study of Empagliflozin.

Keywords: Analytical methods, Type 2 diabetes, SGLT 2 inhibitors, Antidiabetics, Empagliflozin.